Search results
2021 Annual Report. 2022 Proxy Statement. The Investor Relations website contains information about Abbott Laboratories's business for stockholders, potential investors, and financial analysts.
ABBOTT 2023 ANNUAL REPORT 3 Pipeline Productivity In 2023, we continued to introduce a robust stream of important new healthcare products. These included: • Alinity TBI, a laboratory test for concussion • Alinity h, an integrated hematology system for advanced testing of complete blood counts • Alinity m high risk HPV, a new test for
ABBOTT 2022 ANNUAL REPORT COMMITTED. For 135 years, Abbott has focused relentlessly on delivering for our stakeholders. Today, billions of people around the world depend on us in vital ways. We’re committed to honoring that trust.
ABBOTT 2021 ANNUAL REPORT THE ABBOTT WAY The rigors of the pandemic environment have helped to highlight all of the strengths that make Abbott such an enduringly successful company. The continual shifts and disruptions to normal business patterns — supply chain functioning, fluctuating demand in certain areas, workplace operations —
ABBOTT 2020 ANNUAL REPORT DEAR FELLOW SHAREHOLDER: In the most challenging year in living memory, Abbott rose to the test, making major contributions to the global effort to defeat COVID-19. This was consistent with our long history, with our values, and with our purpose as a company. We were built for times like these. ROBERT FORD
Today, Abbott is well positioned in markets where healthcare needs are great and growing fast. ABBOTT 2018 ANNUAL REPORT 3
2023 ANNUAL REPORT.
